Sign in

CIK 0001819411

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Gain Therapeutics, Inc.

Sign in to watch
Ticker
GANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851726310
Phone
+1 301-500-1556
Business address
4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-24 Mack Gene CEO, President Grant or award · Employee Stock Option (right to buy) +200,000 200,000
2025-03-20 Mack Gene CEO, President Grant or award · Employee Stock Option (right to buy) +200,000 200,000
2025-01-06 Mack Gene CEO, President Grant or award · Stock Option (right to buy) +271,325 271,325
2024-08-09 Mack Gene CFO and Interim CEO Purchase +14,400 $1.01 $15K 14,400
2024-04-08 Mack Gene Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +200,000 200,000

Page 1 of 1 · 5 trades